BRISTOL-MYERS SQUIBB COMPANY Costs and Expenses
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Costs and Expenses of $8.89 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY costs and expenses for the quarter ending 2026-06-30 was $8.89B, a 15.33% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY costs and expenses for the quarter ending 2026-03-31 was $8.25B, a 0.24% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY costs and expenses for the quarter ending 2025-12-31 was $11.03B, a 9.33% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY costs and expenses for the quarter ending 2025-09-30 was $9.11B, a 10.85% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY costs and expenses for fiscal 2025 was $38.87B, a 31.43% decline from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY costs and expenses for fiscal 2024 was $56.68B, a 55.00% increase from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY costs and expenses for fiscal 2023 was $36.57B, a 4.89% decline from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY costs and expenses for fiscal 2022 was $38.45B, a 0.42% increase from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.89B 10-Q · filed 2026-07-30 | $17.14B 10-Q · filed 2026-07-30 | $28.17B derived: sum of 3 quarters · filed 2026-07-30 | $37.28B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $8.25B 10-Q · filed 2026-04-30 | $19.28B derived: sum of 2 quarters · filed 2026-04-30 | $28.39B derived: sum of 3 quarters · filed 2026-04-30 | $38.89B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | $11.03B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $20.14B derived: sum of 2 quarters · filed 2026-02-11 | $30.64B derived: sum of 3 quarters · filed 2026-07-30 | $38.87B 10-K · filed 2026-02-11 | |||
| 2025-09-30 | $9.11B 10-Q · filed 2025-10-30 | $19.60B derived: sum of 2 quarters · filed 2026-07-30 | $27.83B 10-Q · filed 2025-10-30 | $40.00B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | $10.50B 10-Q · filed 2026-07-30 | $18.73B 10-Q · filed 2026-07-30 | $30.89B derived: sum of 3 quarters · filed 2026-07-30 | $41.11B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | $8.23B 10-Q · filed 2026-04-30 | $20.40B derived: sum of 2 quarters · filed 2026-04-30 | $30.61B derived: sum of 3 quarters · filed 2026-04-30 | $41.53B derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $12.17B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $22.38B derived: sum of 2 quarters · filed 2026-02-11 | $33.30B derived: sum of 3 quarters · filed 2026-02-11 | $56.68B 10-K · filed 2026-02-11 | |||
| 2024-09-30 | $10.22B 10-Q · filed 2025-10-30 | $21.13B derived: sum of 2 quarters · filed 2025-10-30 | $44.51B 10-Q · filed 2025-10-30 | $54.31B derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-06-30 | $10.91B 10-Q · filed 2025-07-31 | $34.30B 10-Q · filed 2025-07-31 | $44.10B derived: sum of 3 quarters · filed 2026-02-11 | $52.93B derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-03-31 | $23.38B 10-Q · filed 2025-04-24 | $33.18B derived: sum of 2 quarters · filed 2026-02-11 | $42.01B derived: sum of 3 quarters · filed 2026-02-11 | $51.38B derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2023-12-31 | $9.80B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $18.63B derived: sum of 2 quarters · filed 2026-02-11 | $28.00B derived: sum of 3 quarters · filed 2026-02-11 | $36.57B 10-K · filed 2026-02-11 | |||
| 2023-09-30 | $8.83B 10-Q · filed 2024-10-31 | $18.20B derived: sum of 2 quarters · filed 2024-10-31 | $26.76B 10-Q · filed 2024-10-31 | $36.31B derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-06-30 | $9.37B 10-Q · filed 2024-07-26 | $17.93B 10-Q · filed 2024-07-26 | $27.48B derived: sum of 3 quarters · filed 2025-02-12 | $36.49B derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-03-31 | $8.57B 10-Q · filed 2024-04-25 | $18.11B derived: sum of 2 quarters · filed 2025-02-12 | $27.12B derived: sum of 3 quarters · filed 2025-02-12 | $37.05B derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2022-12-31 | $9.55B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $18.56B derived: sum of 2 quarters · filed 2025-02-12 | $28.48B derived: sum of 3 quarters · filed 2025-02-12 | $38.45B 10-K · filed 2025-02-12 | |||
| 2022-09-30 | $9.01B 10-Q · filed 2023-10-26 | $18.94B derived: sum of 2 quarters · filed 2023-10-26 | $28.90B 10-Q · filed 2023-10-26 | $39.03B derived: sum of 4 quarters · filed 2024-02-13 | |||
| 2022-06-30 | $9.93B 10-Q · filed 2023-07-27 | $19.89B 10-Q · filed 2023-07-27 | $30.02B derived: sum of 3 quarters · filed 2024-02-13 | $39.48B derived: sum of 4 quarters · filed 2024-02-13 | |||
| 2022-03-31 | $9.96B 10-Q · filed 2023-04-27 | $20.09B derived: sum of 2 quarters · filed 2024-02-13 | $29.55B derived: sum of 3 quarters · filed 2024-02-13 | $39.70B derived: sum of 4 quarters · filed 2024-02-13 | |||
| 2021-12-31 | $10.13B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $19.59B derived: sum of 2 quarters · filed 2024-02-13 | $29.74B derived: sum of 3 quarters · filed 2024-02-13 | $38.29B 10-K · filed 2024-02-13 | |||
| 2021-09-30 | $9.47B 10-Q · filed 2022-10-26 | $19.62B derived: sum of 2 quarters · filed 2022-10-26 | $28.16B 10-Q · filed 2022-10-26 | $49.68B derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-06-30 | $10.15B 10-Q · filed 2022-07-27 | $18.69B 10-Q · filed 2022-07-27 | $40.21B derived: sum of 3 quarters · filed 2023-02-14 | $48.49B derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-03-31 | $8.54B 10-Q · filed 2022-04-29 | $30.06B derived: sum of 2 quarters · filed 2023-02-14 | $38.34B derived: sum of 3 quarters · filed 2023-02-14 | $46.85B derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2020-12-31 | $21.52B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $29.80B derived: sum of 2 quarters · filed 2023-02-14 | $38.30B derived: sum of 3 quarters · filed 2023-02-14 | $49.39B 10-K · filed 2023-02-14 | |||
| 2020-09-30 | $8.28B 10-Q · filed 2021-10-27 | $16.79B derived: sum of 2 quarters · filed 2021-10-27 | $27.87B 10-Q · filed 2021-10-27 | $35.94B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-06-30 | $8.50B 10-Q · filed 2021-07-28 | $19.59B 10-Q · filed 2021-07-28 | $27.66B derived: sum of 3 quarters · filed 2022-02-09 | $32.32B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-03-31 | $11.09B 10-Q · filed 2021-04-29 | $19.16B derived: sum of 2 quarters · filed 2022-02-09 | $23.82B derived: sum of 3 quarters · filed 2022-02-09 | $28.31B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2019-12-31 | $8.07B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $12.73B derived: sum of 2 quarters · filed 2022-02-09 | $17.23B derived: sum of 3 quarters · filed 2022-02-09 | $21.17B 10-K · filed 2022-02-09 | |||
| 2019-09-30 | $4.66B 10-Q · filed 2020-11-05 | $9.15B derived: sum of 2 quarters · filed 2020-11-05 | $13.10B 10-Q · filed 2020-11-05 | $17.56B derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2019-06-30 | $4.50B 10-Q · filed 2020-08-06 | $8.44B 10-Q · filed 2020-08-06 | $12.91B derived: sum of 3 quarters · filed 2021-02-10 | $16.43B derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2019-03-31 | $3.94B 10-Q · filed 2020-05-07 | $8.41B derived: sum of 2 quarters · filed 2021-02-10 | $11.93B derived: sum of 3 quarters · filed 2021-02-10 | $17.12B derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2018-12-31 | $4.47B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $7.99B derived: sum of 2 quarters · filed 2021-02-10 | $13.18B derived: sum of 3 quarters · filed 2021-02-10 | $16.59B 10-K · filed 2021-02-10 | |||
| 2018-09-30 | $3.52B 10-Q · filed 2019-10-31 | $8.71B derived: sum of 2 quarters · filed 2019-10-31 | $12.13B 10-Q · filed 2019-10-31 | $16.88B derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $5.19B 10-Q · filed 2019-07-25 | $8.60B 10-Q · filed 2019-07-25 | $13.35B derived: sum of 3 quarters · filed 2020-02-24 | $17.42B derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | $3.41B 10-Q · filed 2019-04-25 | $8.16B derived: sum of 2 quarters · filed 2020-02-24 | $12.24B derived: sum of 3 quarters · filed 2020-02-24 | $16.09B derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $4.75B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $8.82B derived: sum of 2 quarters · filed 2020-02-24 | $12.67B derived: sum of 3 quarters · filed 2020-02-24 | $15.64B 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $4.07B 10-Q · filed 2018-10-25 | $7.92B derived: sum of 2 quarters · filed 2018-10-25 | $10.89B 10-Q · filed 2018-10-25 | $15.05B derived: sum of 4 quarters · filed 2019-02-25 | |||
| 2017-06-30 | $3.85B 10-Q · filed 2018-07-26 | $6.82B 10-Q · filed 2018-07-26 | $10.98B derived: sum of 3 quarters · filed 2019-02-25 | $14.34B derived: sum of 4 quarters · filed 2019-02-25 | |||
| 2017-03-31 | $2.97B 10-Q · filed 2018-04-26 | $7.13B derived: sum of 2 quarters · filed 2019-02-25 | $10.49B derived: sum of 3 quarters · filed 2019-02-25 | $13.75B derived: sum of 4 quarters · filed 2019-02-25 | |||
| 2016-12-31 | $4.16B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $7.52B derived: sum of 2 quarters · filed 2019-02-25 | $10.78B derived: sum of 3 quarters · filed 2019-02-25 | $13.51B 10-K · filed 2019-02-25 | |||
| 2016-09-30 | $3.36B 10-Q · filed 2017-10-26 | $6.62B derived: sum of 2 quarters · filed 2017-10-26 | $9.36B 10-Q · filed 2017-10-26 | $14.05B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-30 | $3.26B 10-Q · filed 2017-07-27 | $5.99B 10-Q · filed 2017-07-27 | $10.69B derived: sum of 3 quarters · filed 2018-02-13 | $13.77B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-31 | $2.74B 10-Q · filed 2017-04-27 | $7.43B derived: sum of 2 quarters · filed 2018-02-13 | $10.52B derived: sum of 3 quarters · filed 2018-02-13 | $14.63B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-31 | $4.70B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $7.78B derived: sum of 2 quarters · filed 2018-02-13 | $11.89B derived: sum of 3 quarters · filed 2018-02-13 | $14.48B 10-K · filed 2018-02-13 | |||
| 2015-09-30 | $3.08B 10-Q · filed 2016-10-27 | $7.19B derived: sum of 2 quarters · filed 2016-10-27 | $9.79B 10-Q · filed 2016-10-27 | $14.10B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-06-30 | $4.11B 10-Q · filed 2016-07-28 | $6.70B 10-Q · filed 2016-07-28 | $11.02B derived: sum of 3 quarters · filed 2017-02-21 | $13.94B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-03-31 | $2.59B 10-Q · filed 2016-04-28 | $6.91B derived: sum of 2 quarters · filed 2017-02-21 | $9.82B derived: sum of 3 quarters · filed 2017-02-21 | $13.27B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2014-12-31 | $4.32B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $7.23B derived: sum of 2 quarters · filed 2017-02-21 | $10.67B derived: sum of 3 quarters · filed 2017-02-21 | $13.50B 10-K · filed 2017-02-21 | |||
| 2014-09-30 | $2.91B 10-Q · filed 2015-10-27 | $6.35B derived: sum of 2 quarters · filed 2015-10-27 | $9.18B 10-Q · filed 2015-10-27 | $12.75B derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-06-30 | $3.44B 10-Q · filed 2015-07-23 | $6.27B 10-Q · filed 2015-07-23 | $9.84B derived: sum of 3 quarters · filed 2016-02-12 | $13.09B derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-03-31 | $2.83B 10-Q · filed 2015-04-28 | $6.40B derived: sum of 2 quarters · filed 2016-02-12 | $9.64B derived: sum of 3 quarters · filed 2016-02-12 | $13.16B derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2013-12-31 | $3.57B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $6.82B derived: sum of 2 quarters · filed 2016-02-12 | $10.34B derived: sum of 3 quarters · filed 2016-02-12 | $13.49B 10-K · filed 2016-02-12 | |||
| 2013-09-30 | $3.25B 10-Q · filed 2014-10-24 | $6.76B derived: sum of 2 quarters · filed 2014-10-24 | $9.92B 10-Q · filed 2014-10-24 | $13.60B derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-06-30 | $3.52B 10-Q · filed 2014-07-24 | $6.67B 10-Q · filed 2014-07-24 | $10.35B derived: sum of 3 quarters · filed 2015-02-13 | $15.35B derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-03-31 | $3.16B 10-Q · filed 2014-04-29 | $6.83B derived: sum of 2 quarters · filed 2015-02-13 | $11.83B derived: sum of 3 quarters · filed 2015-02-13 | $15.21B derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2012-12-31 | $3.68B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $8.67B derived: sum of 2 quarters · filed 2015-02-13 | $12.06B derived: sum of 3 quarters · filed 2015-02-13 | $15.28B 10-K · filed 2015-02-13 | |||
| 2012-09-30 | $5.00B 10-Q · filed 2013-10-23 | $8.38B derived: sum of 2 quarters · filed 2013-10-23 | $11.60B 10-Q · filed 2013-10-23 | $15.46B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2012-06-30 | $3.38B 10-Q · filed 2013-07-25 | $6.61B 10-Q · filed 2013-07-25 | $10.47B derived: sum of 3 quarters · filed 2014-02-14 | $13.98B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2012-03-31 | $3.22B 10-Q · filed 2013-04-25 | $7.08B derived: sum of 2 quarters · filed 2014-02-14 | $10.60B derived: sum of 3 quarters · filed 2014-02-14 | $14.24B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2011-12-31 | $3.86B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $7.38B derived: sum of 2 quarters · filed 2014-02-14 | $11.02B derived: sum of 3 quarters · filed 2014-02-14 | $14.26B 10-K · filed 2014-02-14 | |||
| 2011-09-30 | $3.52B 10-Q · filed 2012-10-24 | $7.16B derived: sum of 2 quarters · filed 2012-10-24 | $10.40B 10-Q · filed 2012-10-24 | $14.10B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-06-30 | $3.64B 10-Q · filed 2012-07-25 | $6.89B 10-Q · filed 2012-07-25 | $10.59B derived: sum of 3 quarters · filed 2013-02-15 | $13.77B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-03-31 | $3.24B 10-Q · filed 2012-04-26 | $6.94B derived: sum of 2 quarters · filed 2013-02-15 | $10.13B derived: sum of 3 quarters · filed 2013-02-15 | $13.30B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2010-12-31 | $3.70B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $6.88B derived: sum of 2 quarters · filed 2013-02-15 | $10.06B derived: sum of 3 quarters · filed 2013-02-15 | $13.41B 10-K · filed 2013-02-15 | |||
| 2010-09-30 | $3.18B 10-Q · filed 2011-10-27 | $6.36B derived: sum of 2 quarters · filed 2011-10-27 | $9.71B 10-Q · filed 2011-10-27 | $13.43B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-06-30 | $3.18B 10-Q · filed 2011-07-28 | $6.53B 10-Q · filed 2011-07-28 | $10.24B derived: sum of 3 quarters · filed 2012-02-17 | $13.47B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-03-31 | $3.35B 10-Q · filed 2011-04-28 | $7.07B derived: sum of 2 quarters · filed 2012-02-17 | $10.29B derived: sum of 3 quarters · filed 2012-02-17 | $13.43B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2009-12-31 | $3.71B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $6.94B derived: sum of 2 quarters · filed 2012-02-17 | $10.08B derived: sum of 3 quarters · filed 2012-02-17 | $13.21B 10-K · filed 2012-02-17 | |||
| 2009-09-30 | $3.22B 10-Q · filed 2010-10-26 | $3.76B 10-Q · filed 2009-10-22 | $6.37B derived: sum of 2 quarters · filed 2010-10-26 | $9.49B 10-Q · filed 2010-10-26 | $11.04B 10-Q · filed 2009-10-22 | $10.67B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-06-30 | $3.14B 10-Q · filed 2010-07-22 | $3.64B 10-Q · filed 2009-07-23 | $6.27B 10-Q · filed 2010-07-22 | $7.27B 10-Q · filed 2009-07-23 | $7.44B derived: sum of 3 quarters · filed 2011-02-18 | $11.54B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-03-31 | $3.13B 10-Q · filed 2010-04-29 | $4.30B derived: sum of 2 quarters · filed 2011-02-18 | $8.40B derived: sum of 3 quarters · filed 2011-02-18 | $12.38B derived: sum of 4 quarters · filed 2011-02-18 | |||
| 2008-12-31 | $1.17B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $5.27B derived: sum of 2 quarters · filed 2011-02-18 | $9.26B derived: sum of 3 quarters · filed 2011-02-18 | $12.94B 10-K · filed 2011-02-18 | |||
| 2008-09-30 | $4.10B 10-Q · filed 2009-10-22 | $8.08B derived: sum of 2 quarters · filed 2009-10-22 | $11.77B 10-Q · filed 2009-10-22 | ||||
| 2008-06-30 | $3.98B 10-Q · filed 2009-07-23 | $7.67B 10-Q · filed 2009-07-23 | |||||
| 2007-12-31 | $13.09B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |